XELJANZ - 0069-1001-01 - (TOFACITINIB CITRATE)

Alphabetical Index


Drug Information of XELJANZ

Product NDC: 0069-1001
Proprietary Name: XELJANZ
Non Proprietary Name: TOFACITINIB CITRATE
Active Ingredient(s): 5    mg/1 & nbsp;   TOFACITINIB CITRATE
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of XELJANZ

Product NDC: 0069-1001
Labeler Name: Pfizer Laboratories Div Pfizer Inc
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA203214
Marketing Category: NDA
Start Marketing Date: 20121109

Package Information of XELJANZ

Package NDC: 0069-1001-01
Package Description: 60 TABLET, FILM COATED in 1 BOTTLE (0069-1001-01)

NDC Information of XELJANZ

NDC Code 0069-1001-01
Proprietary Name XELJANZ
Package Description 60 TABLET, FILM COATED in 1 BOTTLE (0069-1001-01)
Product NDC 0069-1001
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name TOFACITINIB CITRATE
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20121109
Marketing Category Name NDA
Labeler Name Pfizer Laboratories Div Pfizer Inc
Substance Name TOFACITINIB CITRATE
Strength Number 5
Strength Unit mg/1
Pharmaceutical Classes

Complete Information of XELJANZ


General Information